They can release IL-1 that induces the expression of anti-tumor cytotoxic lymphocytes from T lymphocytes, which directly kill tumors, or combine with activated lymphokine-activated killer (LAK) cells, natural killer (NK) cells, and tumor-infiltrating lymphocytes to kill tumors [57]. The gene discussed is IL1B; the disease is neoplasm.